NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00182403,Fixed Dose Heparin Study,https://clinicaltrials.gov/study/NCT00182403,,COMPLETED,"FIDO was a multicentred randomized, open-label trial that compared fixed-dose UFH with fixed-dose LMWH for initial treatment of VTE. Patients were followed for 3 months during which they received warfarin (target INR 2.0-3.0).",NO,Venous Thromboembolism|Deep Vein Thrombosis|Pulmonary Embolism,DRUG: UFH 250 U/kg or LMWH 100 U/kg sc twice daily,Symptomatic Venous Thromboembolism|Major Bleeding|Death,aXa ~6h after sc injection on 3rd day of treatment,,McMaster University,Heart and Stroke Foundation of Ontario,ALL,"ADULT, OLDER_ADULT",PHASE3,866,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CTMG-2005-FIDO|#NA3640,1998-09,,2004-05,2005-09-16,,2017-06-07,"Hamilton Health Sciences-General Campus, Hamilton, Ontario, L8L 2X2, Canada|Hamlton Health Sciences -McMaster Campus, Hamilton, Ontario, L8N 3Z5, Canada|St. Joseph's Healthcare Centre, Hamilton, Ontario, L8N 4A6, Canada|Hamilton Health Sciences-Henderson Campus, Hamilton, Ontario, L8V 1C3, Canada|McGill University Health Centre, Montreal, Quebec, H3G 1A4, Canada|CHA Pavillon du Saint-Sacrement, Quebec City, Quebec, Canada|Auckland Hospital, Auckland, New Zealand|Middlemore, Otahuhu, New Zealand",
